VRTX
VRTX
Vertex Pharmaceuticals Incorporated
$452.50
-$0.56 (-0.12%)
Mkt Cap: $114.85B
Home / VRTX / Financial Statements

Vertex Pharmaceuticals Incorporated (VRTX) Financial Statements

Export as clean Markdown. Drag & drop into ChatGPT, Claude, or Gemini.

Metric TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue
$12.26B
$12.07B ↑9.6%
$11.02B ↑11.7%
$9.87B ↑10.5%
$8.93B ↑17.9%
$7.57B
Cost of Revenue
$1.68B
$1.81B ↑18.1%
$1.53B ↑21.3%
$1.26B ↑16.8%
$1.08B ↑19.5%
$904.20M
Gross Profit
$10.57B
$10.27B ↑8.2%
$9.49B ↑10.3%
$8.61B ↑9.6%
$7.85B ↑17.7%
$6.67B
R&D Expenses
$3.95B
$3.75B ↑3.4%
$3.63B ↑14.8%
$3.16B ↑19.1%
$2.66B ↓13.0%
$3.05B
SG&A Expenses
$1.85B
$1.75B ↑19.7%
$1.46B ↑28.8%
$1.14B ↑20.3%
$944.70M ↑12.5%
$840.10M
Operating Income
$4.78B
$4.76B
-$232.90M ↓106.1%
$3.83B ↓11.0%
$4.31B ↑54.8%
$2.78B
Interest Expense
$10.30M
$13.30M ↓56.5%
$30.60M ↓30.6%
$44.10M ↓19.5%
$54.80M ↓10.9%
$61.50M
Income Tax
$827.40M
$690.00M ↓12.0%
$784.10M ↑3.1%
$760.20M ↓16.5%
$910.40M ↑134.5%
$388.30M
Net Income
$4.34B
$3.95B ↑838.1%
-$535.60M ↓114.8%
$3.62B ↑9.0%
$3.32B ↑41.8%
$2.34B
EBITDA
$5.19B
$4.97B ↑921.6%
$486.30M ↓89.4%
$4.61B ↑3.8%
$4.44B ↑52.0%
$2.92B
EPS
16.86
15.32 ↑836.5%
-2.08 ↓115.0%
13.89 ↑8.3%
12.82 ↑42.3%
9.01
Shares Out (Diluted)
1.03B
258.00M ↑0.0%
257.90M ↓1.0%
260.50M ↑0.5%
259.10M ↓0.3%
259.90M